Genetics and Molecular Research · 2015 · 17 citations · 17 references
MedicineImmunologyOncologyCancer ImmunologyMolecular OncologyTumor ImmunologyCancer ImmunotherapyImmunotherapy For Skin CancerInterferon-based TherapyMelanocytic TumorsMelanoma SurgeryAdjuvant Biologic TherapyAdjuvant Therapy After Melanoma SurgeryInterferon Alfa TherapyInterferon Alpha-2b TherapyMelanoma Adjuvant TherapyMelanoma ImmunotherapyMelanoma Neoadjuvant Therapy
Two major subtypes of melanoma include cutaneous melanoma and mucosal melanoma. The latter type is rare and usually occurs in the head and neck region. High-dose interferon-α-2b (IFN-α-2b) has proven effective in the treatment of cutaneous melanoma. Recently, a regimen of temozolomide plus cisplatin was reported more likely to improve relapse-free survival and overall survival than high-dose IFN-α-2b for mucosal melanoma. We conducted this study to analyze the therapeutic effect of high-dose IFN-α-2b for patients with oral mucosal melanoma who had received prior chemotherapy. One hundred and seventeen patients with stage III-IVa oral mucosal melanoma who had received chemotherapy were analyzed. The overall survival and relapse-free survival were compared between the patients with/without high-dose IFN-α-2b. The results indicate that the IFN-α-2b treatment group had a longer relapse-free survival rate (P = 0.0169) as compared to the control group. However, the overall survival was not significant between the two groups (P = 0.096), except in patients in stage IVa, whose overall survival increased by 20 months (P = 0.0146). The adverse reactions included a drug-induced influenza-like syndrome, gastrointestinal responses, myelosuppression, and hepatoxicity, which were predominantly of grade 1-2 and reversible. Thus, patients with resected oral mucosal melanoma, even those who have received chemotherapy, could benefit from the treatment of high-dose IFN-α-2b.
17
Distinct Sets of Genetic Alterations in Melanoma
John A. Curtin, Jane Fridlyand, Toshiro Kageshita et al. · New England Journal of Medicine · 2005 · 2.7K citations · Full text
The National Cancer Data Base report on cutaneous and noncutaneous melanoma
Alfred E. Chang, Lucy Hynds Karnell, Herman R. Menck · Cancer · 1998 · 1.7K citations · Full text
Medicine, Dermatology, Oncology +17
Somatic Activation of KIT in Distinct Subtypes of Melanoma
John A. Curtin, Klaus J. Busam, Daniel Pinkel et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text
Primary mucosal malignant melanoma of the head and neck
Snehal G. Patel, Manju L. Prasad, Margarita Escrig et al. · Head & Neck · 2002 · 457 citations